Q-omics provides the consensus-scored LINC01115 profile across patient tissues and cancer cell-line models. LINC01115 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, LINC01115 is differentially expressed in 7, with the highest sampling consensus in KICH. Additionally, LINC01115 RNA expression shows 7,027 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight READ, KICH, and THYM as cancer lineages where LINC01115 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01115 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01115 survival associations across molecular data types. LINC01115 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01115 RNA expression–survival associations across cancer types. High LINC01115 expression shows unfavorable associations in READ, ACC, THCA, DLBC and LIHC, but favorable associations in UCEC. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for LINC01115 RNA expression.
This table summarizes LINC01115 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01115. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01115 shows lower tumor expression in KICH, KIRC, THCA and KIRP and higher tumor expression in HNSC and LUSC. The KICH box plot shows higher LINC01115 RNA expression in normal versus tumor tissue (log2 FC = −0.683, t-test p < 0.001).
This table shows molecular features associated with LINC01115 in patient tissues and cancer cell lines. In patient samples, LINC01115 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
